EGFR and breast adenocarcinoma: SKBR3 is a non-TNBC breast adenocarcinoma cell line that expresses wild-type EGFR and PC9 is non-small cell lung cancer cell line that expresses EGFR with a delta E746-A750 deletion in the tyrosine kinase domain.